Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/2000
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000WO1999053951A9 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2366305A1 Method for expressing proteins
10/04/2000EP1040190A1 Serine proteinase inhibitors
10/04/2000EP1040117A1 110 human secreted proteins
10/04/2000EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
10/04/2000EP1039894A1 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
10/04/2000EP1039888A1 Method of increasing the production and improving the quality of semen
10/04/2000EP1039843A1 Biodegradable intra vaginal devices
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof
10/04/2000CN1269013A Moleculars withch give out multiple active parts
10/04/2000CN1268889A Novel process for obtg. intermediates
10/04/2000CN1268352A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole
10/04/2000CN1057011C Traditional Chinese medicine for regulating taste, beneifitting liver and kidney and improving intelligence
10/04/2000CN1057002C Traditional Chinese medicine composition for treating female dysgenesis
10/03/2000US6127542 Chemical intermediates to specified pyrazino(2',1':6,1)pyrido(3,4b)indole-1,4-diones which are selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase; to treat cardiovascular disorders
10/03/2000US6127522 CRFG-1a, a target and marker for chronic renal failure
10/03/2000US6127425 A solution of tamoxifen citrate and a mixture of ethanol, a glycol, e.g. propylene glycol, glycerol, and water; high concentration to be the equivalent of solid dosage of tasmoxifen; crystallization inhibition; complexes-free
10/03/2000US6127401 Treatment of prostate disorders, angiogenic disorders, neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease
10/03/2000US6127398 An enzyme inhibitor for the inhibition of phosphodiesterase typeiv or the production of tumor necrosis factor in a mammal; treating asthma, arthritis, bronchitis, chronic obstructive airway disease, psoriasis, allergic rhinitis
10/03/2000US6127396 Imidazoline compounds
10/03/2000US6127391 Compounds with growth hormone releasing properties
10/03/2000US6127389 Benzimidazole derivatives as bradykinin agonists
10/03/2000US6127367 Administering an aldose reductase inhibitor as an antiischemic agent
10/03/2000US6127363 Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
10/03/2000US6126959 Pharmaceutical composition for treating dysmenorrhea and premature labor
10/03/2000CA2179746C Novel therapeutic carbohydrate blends useful for aiding premenstrual syndrome
10/03/2000CA2000342C Novel peptidase inhibitors
09/2000
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056739A1 Thienopyrimidine compounds, their production and use
09/28/2000WO2000056719A1 FUSED PYRIDOPYRIDAZINE INHIBITORS OF cGMP PHOSPHODIESTERASE
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056685A1 Methods for the preparation of biphenyl isoxazole sulfonamides
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056366A1 Gel-microemulsion formulations
09/28/2000WO2000056353A2 A uro-genital condition treatment system
09/28/2000WO2000056323A1 Treatment of certain cancers associated with weight gain
09/28/2000WO2000056302A2 Vanadium (iv) complexes containing catacholate ligand and having spermicidal activity
09/28/2000WO2000056296A2 Compositions for improving fertility
09/28/2000WO2000056144A1 Human sperm surface antigen
09/28/2000WO2000043392A3 Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2368023A1 Fused pyridopyridazine inhibitors of cgmp phosphodiesterase
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367916A1 Methods for the preparation of biphenyl isoxazole sulfonamides
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367266A1 Gel-microemulsion formulations
09/28/2000CA2367118A1 A uro-genital condition treatment system
09/28/2000CA2367045A1 Treatment of certain cancers associated with weight gain
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/27/2000EP1038863A2 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
09/27/2000EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
09/27/2000EP1037985A1 Restin and methods of use thereof
09/27/2000EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
09/27/2000EP1037970A1 Secreted proteins and polynucleotides encoding them
09/27/2000EP1037908A2 Human tumor necrosis factor-r2-like proteins
09/27/2000EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
09/27/2000EP1037616A2 Combination of alpha-adrenergic blockers and cgmp levels-elevating compounds effective for the treatment of impotence
09/27/2000EP0733052B1 Bicyclene derivatives, their production and use
09/27/2000EP0612216B1 Phospholipid antimicrobial compositions
09/27/2000CN1267552A Medicated feminine napkin and its making process
09/26/2000US6124337 Treating male impotence by orally ingesting a mixture comprising a disintegrant to accelerate dissolution a phentolamine vasodilator effective within one hour prior to attempting sexual intercourse
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/26/2000US6124263 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
09/26/2000CA2137832C Inhibitors of angiotensin i chymase(s) including human heart chymase
09/21/2000WO2000055634A1 Grb14 and the insulin receptor and screening of novel medicines
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000054809A1 Cervical ripening agent and cervical ripening method
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054794A1 Wafer delivery system
09/21/2000WO2000054777A1 Controlled release of sildenafil delivered by sublingual or buccal administration
09/21/2000WO2000054774A1 Apomorphine and sildenafil composition
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000039154A3 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000010551A3 Methods of using and compositions comprising dopamine reuptake inhibitors
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367605A1 Apomorphine and sildenafil composition
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367213A1 Novel antiangiogenic peptides
1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 557